Immunogenicity, Tolerability and Safety of One or Two Doses of an Adjuvanted Swine-origin A H1N1 Influenza Vaccine in Healthy Subjects 18 or More Years of Age Both Vaccinated and Not Yet Vaccinated Against Seasonal Influenza 2009/10
Clinical trial NCT00992212 · COMPLETED
Trial details
- NCT number
- NCT00992212
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2009-10-01
- Enrollment
- 418
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.